Ionis Pharmaceuticals reported $130M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Agios Pharmaceuticals USD 42.97M 1.7M Dec/2025
Alnylam Pharmaceuticals USD 285.06M 22.47M Dec/2025
Arrowhead Research USD 46.02M 8.84M Dec/2025
Astellas Pharma JPY 221.78B 14.94B Dec/2025
BioCryst Pharmaceuticals USD 95.78M 12.77M Dec/2025
BioMarin Pharmaceutical USD 322.21M 98.79M Dec/2025
Celltrion KRW 249.98B 16.36B Sep/2025
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Deva Holding AS TRY 462.26M 48.18M Sep/2023
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Esperion Therapeutics USD 39.42M 456K Dec/2025
Exelixis USD 123.02M 19.9M Dec/2025
Halozyme Therapeutics USD 64.64M 27.11M Dec/2025
Ionis Pharmaceuticals USD 130M 43.43M Dec/2025
Kangmei Pharma CNY 274.41M 15.05M Sep/2025
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 2.84M 4.19M Dec/2025
Moderna USD 308M 40M Dec/2025
Nektar Therapeutics USD 10.17M 10.17M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
Neurocrine Biosciences USD 301.8M 10.2M Dec/2025
Novartis USD 3.44B 128M Dec/2025
Omeros USD 11.32M 2.48M Sep/2024
OPKO Health USD 50.52M 3.28M Dec/2025
Organigram Holdings CAD 7.73M 1.13M Dec/2025
Ovoca Bio EUR 632K 2.33M Jun/2025
Pfizer USD 4.08B 894M Dec/2025
Pharma Mar EUR 17.31M 3.6M Dec/2025
PTC Therapeutics USD 87.2M 3.15M Dec/2025
Qiagen NV USD 153.88M 10.77M Dec/2025
Regeneron Pharmaceuticals USD 775M 117.2M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sarepta Therapeutics USD 105.38M 28.27M Dec/2025
Sartorius EUR 218.7M 6.5M Sep/2025
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Tilray USD 24.85M 1.7M Sep/2025
Ultragenyx Pharmaceutical USD 89M 2.38M Dec/2025
Vertex Pharmaceuticals USD 487M 41.9M Dec/2025
Zealand Pharma A/S 91.81M 99.04M Dec/2025
Zz Pientze Pharmaceu CNY 171.91M 343.2M Sep/2025